Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells

被引:40
作者
Hattori, Yoshiyuki [1 ]
Ding, Wu-xiao [1 ]
Maitani, Yoshie [1 ]
机构
[1] Hoshi Univ, Dept Fine Drug Targeting Res, Inst Med Chem, Shinagawa Ku, Tokyo 1428501, Japan
关键词
cationic nanoparticles; gene delivery; transfection; OH-Chol; DC-Chol; PC-3; cells; NONIONIC SURFACTANTS; LIPOSOME COMPLEXES; DELIVERY; DNA; FORMULATIONS; EXPRESSION; MELANOMA; SERUM; OPTIMIZATION; LIPOPLEXES;
D O I
10.1016/j.jconrel.2007.04.012
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Optimal gene therapy for tumors must deliver DNA to tumor cells with high efficiency and minimal toxicity. It has been reported that in nonviral gene delivery, the hydroxyethyl group at the amino terminal in cationic lipid was important for high transfection efficiency. Therefore, in this study, we developed new cationic nanoparticles (NP-OH) composed of cholesteryl-3 beta-carboxyamidoethylene-N-hydroxyethylamine and Tween 80, and optimized in vitro and in vivo transfections for potential use as a non-viral DNA vector into human prostate tumor PC-3 cells and xenografts.' In vitro transfection resulted in efficient DNA transfer when positive-charged nanoplex was prepared in the presence of sodium chloride (NaCl). In in vivo transfection, negative-charged nanoplex formed in water strongly induced the gene expression compared with positive-charged nanoplex when directly transfected into xenografts. These transfection efficiencies in vitro and in vivo were comparable to each commercial product. Furthermore, NP-OH nanoplexes displayed no induction of tumor necrosis factor (TNF)-alpha when administered by intravenous injection. The results of the experiments provided optimal conditions to form NP-OH nanoplex for gene delivery in vitro and in vivo. NP-OH is a potential non-viral DNA vector for the local treatment of tumor and in vitro. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:122 / 130
页数:9
相关论文
共 32 条
[1]
Lipoplex size determines lipofection efficiency with or without serum [J].
Almofti, MR ;
Harashima, H ;
Shinohara, Y ;
Almofti, A ;
Li, WH ;
Kiwada, H .
MOLECULAR MEMBRANE BIOLOGY, 2003, 20 (01) :35-43
[2]
A polymer library approach to suicide gene therapy for cancer [J].
Anderson, DG ;
Peng, WD ;
Akinc, A ;
Hossain, N ;
Kohn, A ;
Padera, R ;
Langer, R ;
Sawicki, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (45) :16028-16033
[3]
Cationic lipid-mediated gene delivery to murine lung: Correlation of lipid hydration with in vivo transfection activity [J].
Bennett, MJ ;
Aberle, AM ;
Balasubramaniam, RP ;
Malone, JG ;
Malone, RW ;
Nantz, MH .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (25) :4069-4078
[4]
Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA [J].
Clark, PR ;
Stopeck, AT ;
Ferrari, M ;
Parker, SE ;
Hersh, EM .
CANCER GENE THERAPY, 2000, 7 (06) :853-860
[5]
DASS CR, 1999, J PHARM PHARMACOL, V51, P570
[6]
Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer [J].
Egilmez, NK ;
Iwanuma, Y ;
Bankert, RB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (01) :169-173
[7]
Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes [J].
Escriou, V ;
Ciolina, C ;
Lacroix, F ;
Byk, G ;
Scherman, D ;
Wils, P .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1368 (02) :276-288
[8]
FELGNER JH, 1994, J BIOL CHEM, V269, P2550
[9]
Comparative study of transfection efficiency of cationic cholesterols mediated by liposomes-based gene delivery [J].
Hasegawa, S ;
Hirashima, N ;
Nakanishi, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (09) :1299-1302
[10]
HASHIDA M, 2005, CHEM PHARM BULL, V53, P580